<div id=toc></div>

# Table of Contents

- [q-bio.QM](#q-bio.QM) [Total: 2]
- [cs.LG](#cs.LG) [Total: 1]
- [cs.DS](#cs.DS) [Total: 1]
- [cs.CL](#cs.CL) [Total: 1]
- [eess.SP](#eess.SP) [Total: 1]


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [1] [GLOMIA-Pro: A Generalizable Longitudinal Medical Image Analysis Framework for Disease Progression Prediction](https://arxiv.org/abs/2507.12500)
*Shuaitong Zhang,Yuchen Sun,Yong Ao,Xuehuan Zhang,Ruoshui Yang,Jiantao Xu,Zuwu Ai,Haike Zhang,Xiang Yang,Yao Xu,Kunwei Li,Duanduan Chen*

Main category: q-bio.QM

TL;DR: 提出了GLOMIA-Pro框架，用于纵向医学图像分析和疾病进展预测，通过分段正交注意力机制和进展感知融合模块，有效解决了表示坍塌问题，在膝关节骨关节炎和食管癌治疗评估中表现优异


<details>
  <summary>Details</summary>
Motivation: 现有纵向医学图像分析方法存在三个关键限制：(1)缺乏适用于多种疾病进展预测任务的通用框架；(2)经常忽视疾病分期固有的序数性质；(3)由于相邻时间点结构相似性导致的表示坍塌问题，可能掩盖细微但具有判别性的进展生物标志物

Method: 提出GLOMIA-Pro框架，包含两个核心组件：(1)进展表示提取模块，引入分段正交注意力机制和新颖的序数进展约束，用于解耦与疾病进展相关的细粒度时间影像变化；(2)进展感知融合模块，采用重新设计的跳跃连接架构，将学习到的进展表示与当前影像表示整合，有效缓解跨时间融合过程中的表示坍塌问题

Result: 在两个不同的临床应用中验证：膝关节骨关节炎严重程度预测和食管癌治疗反应评估，GLOMIA-Pro持续优于七种最先进的纵向分析方法。消融研究进一步确认了各个组件的贡献

Conclusion: GLOMIA-Pro框架在多种临床场景中展现出鲁棒性和通用性，有效解决了纵向医学图像分析中的关键技术挑战，为疾病进展预测提供了一个通用且有效的解决方案

Abstract: Longitudinal medical images are essential for monitoring disease progression
by capturing spatiotemporal changes associated with dynamic biological
processes. While current methods have made progress in modeling spatiotemporal
patterns, they face three key limitations: (1) lack of generalizable framework
applicable to diverse disease progression prediction tasks; (2) frequent
overlook of the ordinal nature inherent in disease staging; (3) susceptibility
to representation collapse due to structural similarities between adjacent time
points, which can obscure subtle but discriminative progression biomarkers. To
address these limitations, we propose a Generalizable LOngitudinal Medical
Image Analysis framework for disease Progression prediction (GLOMIA-Pro).
GLOMIA-Pro consists of two core components: progression representation
extraction and progression-aware fusion. The progression representation
extraction module introduces a piecewise orthogonal attention mechanism and
employs a novel ordinal progression constraint to disentangle finegrained
temporal imaging variations relevant to disease progression. The
progression-aware fusion module incorporates a redesigned skip connection
architecture which integrates the learned progression representation with
current imaging representation, effectively mitigating representation collapse
during cross-temporal fusion. Validated on two distinct clinical applications:
knee osteoarthritis severity prediction and esophageal cancer treatment
response assessment, GLOMIA-Pro consistently outperforms seven state-of-the-art
longitudinal analysis methods. Ablation studies further confirm the
contribution of individual components, demonstrating the robustness and
generalizability of GLOMIA-Pro across diverse clinical scenarios.

</details>


### [2] [Continued domain-specific pre-training of protein language models for pMHC-I binding prediction](https://arxiv.org/abs/2507.13077)
*Sergio E. Mares,Ariel Espinoza Weinberger,Nilah M. Ioannidis*

Main category: q-bio.QM

TL;DR: 论文探讨了通过领域特定的持续预训练改进蛋白质语言模型，以预测pMHC-I结合亲和力，解决了数据稀缺和噪声问题。


<details>
  <summary>Details</summary>
Motivation: 由于HLA等位基因的极端多样性、数据稀缺和实验噪声，现有方法在预测pMHC-I结合亲和力时表现不佳，尤其是对低代表性等位基因和定量预测。

Method: 从ESM Cambrian模型出发，通过掩码语言建模（MLM）对HLA相关肽段进行持续预训练，测试两种输入格式（单独肽段序列或肽段与HLA重链序列拼接），并仅使用高质量定量数据微调IC50预测。

Result: 该方法避免了质谱偏差，专注于高质量数据，改进了pMHC-I结合亲和力的预测。

Conclusion: 领域特定的持续预训练能有效提升蛋白质语言模型在pMHC-I结合亲和力预测中的表现。

Abstract: Predicting peptide--major histocompatibility complex I (pMHC-I) binding
affinity remains challenging due to extreme allelic diversity ($\sim$30,000 HLA
alleles), severe data scarcity for most alleles, and noisy experimental
measurements. Current methods particularly struggle with underrepresented
alleles and quantitative binding prediction. We test whether domain-specific
continued pre-training of protein language models is beneficial for their
application to pMHC-I binding affinity prediction. Starting from ESM Cambrian
(300M parameters), we perform masked-language modeling (MLM)-based continued
pre-training on HLA-associated peptides (epitopes), testing two input formats:
epitope sequences alone versus epitopes concatenated with HLA heavy chain
sequences. We then fine-tune for functional IC$_{50}$ binding affinity
prediction using only high-quality quantitative data, avoiding mass
spectrometry biases that are inherited by existing methods.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [3] [Assay2Mol: large language model-based drug design using BioAssay context](https://arxiv.org/abs/2507.12574)
*Yifan Deng,Spencer S. Ericksen,Anthony Gitter*

Main category: cs.LG

TL;DR: Assay2Mol利用大型语言模型从生物化学筛选数据中生成候选药物分子，优于现有方法。


<details>
  <summary>Details</summary>
Motivation: 生物化学筛选数据中的非结构化文本蕴含丰富信息，但未被充分利用。

Method: Assay2Mol通过检索类似目标的现有筛选数据，利用上下文学习生成候选分子。

Result: Assay2Mol在生成候选配体分子方面优于现有机器学习方法，且分子更易合成。

Conclusion: Assay2Mol为早期药物发现提供了高效工具，充分利用了现有数据。

Abstract: Scientific databases aggregate vast amounts of quantitative data alongside
descriptive text. In biochemistry, molecule screening assays evaluate the
functional responses of candidate molecules against disease targets.
Unstructured text that describes the biological mechanisms through which these
targets operate, experimental screening protocols, and other attributes of
assays offer rich information for new drug discovery campaigns but has been
untapped because of that unstructured format. We present Assay2Mol, a large
language model-based workflow that can capitalize on the vast existing
biochemical screening assays for early-stage drug discovery. Assay2Mol
retrieves existing assay records involving targets similar to the new target
and generates candidate molecules using in-context learning with the retrieved
assay screening data. Assay2Mol outperforms recent machine learning approaches
that generate candidate ligand molecules for target protein structures, while
also promoting more synthesizable molecule generation.

</details>


<div id='cs.DS'></div>

# cs.DS [[Back]](#toc)

### [4] [Computing and Bounding Equilibrium Concentrations in Athermic Chemical Systems](https://arxiv.org/abs/2507.12699)
*Hamidreza Akef,Minki Hhan,David Soloveichik*

Main category: cs.DS

TL;DR: 论文提出了一种迭代算法，用于在聚合物-单体水平上计算平衡浓度，重点在于满足详细平衡条件，同时提高目标聚合物的浓度并降低非目标聚合物的浓度。


<details>
  <summary>Details</summary>
Motivation: 计算分子复合物的平衡浓度通常需要数值方法，而在聚合物-单体水平上，现有方法往往依赖自由能参数。本研究聚焦于无热力学相互作用的情况，适用于DNA纳米技术中的强键合（基于域）体系。

Method: 开发了一种迭代算法，用于分配聚合物浓度以满足详细平衡条件，确保目标聚合物浓度高而非目标聚合物浓度低。

Result: 算法不仅提供了实际执行的方法，还为非目标聚合物浓度的上限提供了理论支持，将离散配置的组合论证与实值浓度联系起来。

Conclusion: 该方法为设计和验证由熵力区分配置的平衡浓度提供了新框架，并在减少DNA逻辑和信号传播中的泄漏方面展示了应用潜力。

Abstract: Computing equilibrium concentrations of molecular complexes is generally
analytically intractable and requires numerical approaches. In this work we
focus on the polymer-monomer level, where indivisible molecules (monomers)
combine to form complexes (polymers). Rather than employing free-energy
parameters for each polymer, we focus on the athermic setting where all
interactions preserve enthalpy. This setting aligns with the strongly bonded
(domain-based) regime in DNA nanotechnology when strands can bind in different
ways, but always with maximum overall bonding -- and is consistent with the
saturated configurations in the Thermodynamic Binding Networks (TBNs) model.
Within this context, we develop an iterative algorithm for assigning polymer
concentrations to satisfy detailed-balance, where on-target (desired) polymers
are in high concentrations and off-target (undesired) polymers are in low. Even
if not directly executed, our algorithm provides effective insights into upper
bounds on concentration of off-target polymers, connecting combinatorial
arguments about discrete configurations such as those in the TBN model to
real-valued concentrations. We conclude with an application of our method to
decreasing leak in DNA logic and signal propagation. Our results offer a new
framework for design and verification of equilibrium concentrations when
configurations are distinguished by entropic forces.

</details>


<div id='cs.CL'></div>

# cs.CL [[Back]](#toc)

### [5] [Improving Drug Identification in Overdose Death Surveillance using Large Language Models](https://arxiv.org/abs/2507.12679)
*Arthur J. Funnell,Panayiotis Petousis,Fabrice Harel-Canada,Ruby Romero,Alex A. T. Bui,Adam Koncsol,Hritika Chaturvedi,Chelsea Shover,David Goodman-Meza*

Main category: cs.CL

TL;DR: 论文提出使用NLP模型（如BioClinicalBERT）自动分类药物过量死亡报告，显著优于传统方法和通用模型，支持实时监测。


<details>
  <summary>Details</summary>
Motivation: 美国药物过量死亡数据因依赖手工ICD-10编码而延迟且不准确，需高效自动化解决方案。

Method: 评估多种NLP方法，包括传统分类器、BERT变体和大型语言模型，使用内部和外部数据集验证。

Result: BioClinicalBERT表现最佳，内部测试F1>=0.998，外部验证F1=0.966，优于其他模型。

Conclusion: NLP模型（尤其是BioClinicalBERT）能高效准确分类药物过量死亡数据，加速监测流程。

Abstract: The rising rate of drug-related deaths in the United States, largely driven
by fentanyl, requires timely and accurate surveillance. However, critical
overdose data are often buried in free-text coroner reports, leading to delays
and information loss when coded into ICD (International Classification of
Disease)-10 classifications. Natural language processing (NLP) models may
automate and enhance overdose surveillance, but prior applications have been
limited. A dataset of 35,433 death records from multiple U.S. jurisdictions in
2020 was used for model training and internal testing. External validation was
conducted using a novel separate dataset of 3,335 records from 2023-2024.
Multiple NLP approaches were evaluated for classifying specific drug
involvement from unstructured death certificate text. These included
traditional single- and multi-label classifiers, as well as fine-tuned
encoder-only language models such as Bidirectional Encoder Representations from
Transformers (BERT) and BioClinicalBERT, and contemporary decoder-only large
language models such as Qwen 3 and Llama 3. Model performance was assessed
using macro-averaged F1 scores, and 95% confidence intervals were calculated to
quantify uncertainty. Fine-tuned BioClinicalBERT models achieved near-perfect
performance, with macro F1 scores >=0.998 on the internal test set. External
validation confirmed robustness (macro F1=0.966), outperforming conventional
machine learning, general-domain BERT models, and various decoder-only large
language models. NLP models, particularly fine-tuned clinical variants like
BioClinicalBERT, offer a highly accurate and scalable solution for overdose
death classification from free-text reports. These methods can significantly
accelerate surveillance workflows, overcoming the limitations of manual ICD-10
coding and supporting near real-time detection of emerging substance use
trends.

</details>


<div id='eess.SP'></div>

# eess.SP [[Back]](#toc)

### [6] [Disentangling coincident cell events using deep transfer learning and compressive sensing](https://arxiv.org/abs/2507.13176)
*Moritz Leuthner,Rafael Vorländer,Oliver Hayden*

Main category: eess.SP

TL;DR: 提出了一种结合全卷积神经网络（FCN）和压缩感知（CS）的混合框架，用于解决单细胞分析中信号重叠问题，显著提高了事件恢复率和分类准确性。


<details>
  <summary>Details</summary>
Motivation: 解决单细胞分析中因信号重叠导致的信号保真度下降问题，提升诊断和细胞治疗的准确性。

Method: 使用FCN估计重叠事件数量，结合CS模块重构单个信号成分，恢复单细胞特征（如速度、振幅、直径）。

Result: 相比传统算法，恢复率提高21%，分类准确性超过97%。

Conclusion: 该框架为下一代非光学单细胞传感平台奠定了基础，扩展了细胞计数在转化医学中的应用。

Abstract: Accurate single-cell analysis is critical for diagnostics, immunomonitoring,
and cell therapy, but coincident events - where multiple cells overlap in a
sensing zone - can severely compromise signal fidelity. We present a hybrid
framework combining a fully convolutional neural network (FCN) with compressive
sensing (CS) to disentangle such overlapping events in one-dimensional sensor
data. The FCN, trained on bead-derived datasets, accurately estimates
coincident event counts and generalizes to immunomagnetically labeled CD4+ and
CD14+ cells in whole blood without retraining. Using this count, the CS module
reconstructs individual signal components with high fidelity, enabling precise
recovery of single-cell features, including velocity, amplitude, and
hydrodynamic diameter. Benchmarking against conventional state-machine
algorithms shows superior performance - recovering up to 21% more events and
improving classification accuracy beyond 97%. Explinability via class
activation maps and parameterized Gaussian template fitting ensures
transparency and clinical interpretability. Demonstrated with magnetic flow
cytometry (MFC), the framework is compatible with other waveform-generating
modalities, including impedance cytometry, nanopore, and resistive pulse
sensing. This work lays the foundation for next-generation non-optical
single-cell sensing platforms that are automated, generalizable, and capable of
resolving overlapping events, broadening the utility of cytometry in
translational medicine and precision diagnostics, e.g. cell-interaction
studies.

</details>
